Back to search
FDAFDA · Food and drugs·Recall number Z-1724-2014

Synergy XVI Intended for radiation therapy treatment.

Published June 25, 2014 · Recall initiated: April 23, 2014

Summary

FDA records medical device Class II recall Z-1724-2014, published June 25, 2014 and initiated April 23, 2014. Recalling firm: Elekta, Inc.; Status: Terminated; Reported quantity: 380 US; Lot: XVI R4.0 to R4.2.1, R4.5.0, R4.5.1, and R5.0.0 to R5.0.1. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

XVI can incorrectly calculate the target position of the treatment table.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Elekta, Inc.
Distributor
Worldwide Distribution - USA including the states of AZ, CT, IA, OH, MD, MI, MN, NV, TX and VA., and the countries of India, Ireland, Malta, Netherlands, South Africa and UK.
Lot
XVI R4.0 to R4.2.1, R4.5.0, R4.5.1, and R5.0.0 to R5.0.1
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was Synergy XVI Intended for radiation therapy treatment. recalled?

Yes. FDA published recall Z-1724-2014 on June 25, 2014. Reported hazard: XVI can incorrectly calculate the target position of the treatment table.

What should I do if I have this product?

Voluntary: Firm initiated · Letter